Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Breast Neoplasms × Anesthesia, General × Clear all

Phase

Status

Completed 8 Unknown 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Urinary Bladder Neoplasms 1 Recurrence 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Multiple Pulmonary Nodules 1 Lung Neoplasms 1 Fibroadenoma 1 Breast Neoplasms 1

Interventions

Trastuzumab 16 Capecitabine 16 pertuzumab 14 Docetaxel 12 Cyclophosphamide 11 Carboplatin 11 pyrotinib 10 Paclitaxel 10 Letrozole 10 Drug Therapy 9 sacituzumab govitecan 8 Standard of Care 8 Radiotherapy 8 Fulvestrant 8 eribulin 7 trastuzumab deruxtecan 6 exemestane 6 abemaciclib 6 Tamoxifen 6 Epirubicin 6 Anastrozole 6 pembrolizumab 5 palbociclib 5 dalpiciclib 5 camrelizumab 4 Vinorelbine 4 Surveys and Questionnaires 4 Sentinel Lymph Node Biopsy 4 Neoadjuvant Therapy 4 Magnetic Resonance Spectroscopy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06910280 2025-04-04

ESCAL

Centre Hospitalier Universitaire de Besancon

Phase NA Not yet recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡